Pathkind Labs is a rapidly growing diagnostic service provider in India, established in 2016 and promoted by Mankind Pharma. Headquartered in Gurugram, Haryana, the company operates over 70 diagnostic laboratories and more than 2,000 collection centers across 20+ states, focusing on delivering quality diagnostics to Tier 2, 3, and 4 cities. 

The laboratories are NABL accredited, ensuring adherence to national quality standards. Pathkind Labs offers a comprehensive range of diagnostic services, including pathology and radiology tests, with specialties in oncology, neurology, gynecology, and nephrology. 

In 2022, the company received an investment of ₹194.4 crore from Motilal Oswal Private Equity, supporting its expansion plans. Pathkind Labs continues to enhance its presence, aiming to provide accessible and affordable diagnostic services across India.